PitchBook-2025年二季度卫生技术公共报表和评估指南（英）-2025

2025-07资本市场10免费

📄 文件全名: 《PitchBook-2025年二季度卫生技术公共报表和评估指南（英）-2025-10页.pdf》
🎯 适合读者: 投资人行业研究员
📊 核心数据: MultiPlan), up 248% YTD, to Veradigm, down 48% YTD. Telehealth platform Hims & Hers continued its volatile 2025. In Q2, prices
GLP-1s at a discount. However, shares dropped 30% when Novo abruptly called off the deal. Despite this setback, Hims ended the
quarter up 98% YTD.
• Subsector highlights: Whereas the S&P 500 and NASDAQ delivered 10% returns over the last 90 days, the virtual care & remote
patient monitoring (RPM) segment outperformed with a median return of 19%. The sector was led by strong gains for Modivcare
🏷️ 核心议题: #IPO

📦 本报告属于月份合集

购买后将获得「2025 年 7 月报告合集」 · 共 2181 份报告打包下载链接

点击获取云盘下载链接

报告摘要

EMERGING TECH RESEARCH PitchBook Data, Inc. Nizar Tarhuni Executive Vice President of Research

❓ 常见问题

《PitchBook-2025年二季度卫生技术公共报表和评估指南（英）-2025》主要包含哪些内容?

EMERGING TECH RESEARCH PitchBook Data, Inc. Nizar Tarhuni Executive Vice President of Research核心数据:MultiPlan), up 248% YTD, to Veradigm, down 48% YTD. Telehealth platform Hims & Hers continued its volatile 2025. In Q2, prices;GLP-1s at a discount. However, shares dropped 30% when Novo abruptly called off the deal. Despite this setback, Hims ended the;quarter up 98% YTD.。

这份报告覆盖哪一年、篇幅多大?

覆盖 2025 年,全文约 10。

这份报告是免费的吗?如何获取?

本报告免费查阅,登录资料宝后即可在线获取完整内容。

这份报告适合哪些读者?

适合投资人、行业研究员等读者参考。

报告涉及哪些关键议题?

重点分析了IPO等议题。